{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T03:41:34Z","timestamp":1784432494687,"version":"3.55.0"},"reference-count":32,"publisher":"Spandidos Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.3892\/or.2016.4748","type":"journal-article","created":{"date-parts":[[2016,4,15]],"date-time":"2016-04-15T05:27:36Z","timestamp":1460698056000},"page":"3600-3606","source":"Crossref","is-referenced-by-count":20,"title":["Improved antitumor activity and reduced myocardial toxicity of doxorubicin encapsulated in MPEG-PCL nanoparticles"],"prefix":"10.3892","volume":"35","author":[{"given":"CHUNTANG","family":"SUN","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LE","family":"ZHOU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MALING","family":"GOU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SHUAI","family":"SHI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TAO","family":"LI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JINYI","family":"LANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2016,4,15]]},"reference":[{"key":"key20180107211613_b1-or-35-06-3600","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1093\/annonc\/mdp425","article-title":"High dose intensity doxorubicin in aggressive non-Hodgkin's lymphoma: A literature-based meta-analysis","volume":"21","author":"Azim","year":"2010","journal-title":"Ann Oncol"},{"key":"key20180107211613_b2-or-35-06-3600","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/S0140-6736(05)80116-3","article-title":"Doxorubicin adjuvant combinations for breast cancer","volume":"342","author":"Sauter","year":"1993","journal-title":"Lancet"},{"key":"key20180107211613_b3-or-35-06-3600","doi-asserted-by":"crossref","first-page":"707","DOI":"10.4161\/cbt.28557","article-title":"Pegylated liposomal doxorubicin in the management of ovarian cancer: A systematic review and metaanalysis of randomized trials","volume":"15","author":"Staropoli","year":"2014","journal-title":"Cancer Biol Ther"},{"key":"key20180107211613_b4-or-35-06-3600","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/CAD.0b013e3283198058","article-title":"Long-term response to pegylated liposomal doxorubicin in patients with metastatic soft tissue sarcomas","volume":"20","author":"Grenader","year":"2009","journal-title":"Anticancer Drugs"},{"key":"key20180107211613_b5-or-35-06-3600","doi-asserted-by":"crossref","first-page":"21629","DOI":"10.3390\/ijms141121629","article-title":"A novel insight into the cardiotoxicity of antineoplastic drug doxorubicin","volume":"14","author":"Heger","year":"2013","journal-title":"Int J Mol Sci"},{"key":"key20180107211613_b6-or-35-06-3600","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1159\/000265166","article-title":"Doxorubicin cardiomyopathy","volume":"115","author":"Chatterjee","year":"2010","journal-title":"Cardiology"},{"key":"key20180107211613_b7-or-35-06-3600","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1038\/509S58a","article-title":"Nanotechnology: Deliver on a promise","volume":"509","author":"Wright","year":"2014","journal-title":"Nature"},{"key":"key20180107211613_b8-or-35-06-3600","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1007\/s11095-009-9929-8","article-title":"Self-assembled hydrophobic honokiol loaded MPEG-PCL diblock copolymer micelles","volume":"26","author":"Gou","year":"2009","journal-title":"Pharm Res"},{"key":"key20180107211613_b9-or-35-06-3600","first-page":"1557","article-title":"Antitumor activity of monomethoxy poly(ethylene glycol)-poly(\u03b5-caprolactone) micelle-encapsulated doxorubicin against mouse melanoma","volume":"25","author":"Zheng","year":"2011","journal-title":"Oncol Rep"},{"key":"key20180107211613_b10-or-35-06-3600","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1182\/blood.V101.1.253","article-title":"Mac-1 (CD11b\/CD18) is crucial for effective Fc receptor-mediated immunity to melanoma","volume":"101","author":"van Spriel","year":"2003","journal-title":"Blood"},{"key":"key20180107211613_b11-or-35-06-3600","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1023\/A:1022616223359","article-title":"Anti-tumor immunoglobulin M increases lung metastasis in an experimental model of malignant melanoma","volume":"20","author":"Tsai","year":"2003","journal-title":"Clin Exp Metastasis"},{"key":"key20180107211613_b12-or-35-06-3600","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1038\/491S58a","article-title":"Nanotechnology: Carrying drugs","volume":"491","author":"Bourzac","year":"2012","journal-title":"Nature"},{"key":"key20180107211613_b13-or-35-06-3600","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1097\/RLU.0b013e3181b7d76f","article-title":"Doxorubicin-induced cardiac toxicity and cardiac rest gated blood pool imaging","volume":"34","author":"Aiken","year":"2009","journal-title":"Clin Nucl Med"},{"key":"key20180107211613_b14-or-35-06-3600","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1021\/mp5000373","article-title":"Codelivery of doxorubicin and paclitaxel by cross-linked multilamellar liposome enables synergistic antitumor activity","volume":"11","author":"Liu","year":"2014","journal-title":"Mol Pharm"},{"key":"key20180107211613_b15-or-35-06-3600","first-page":"229","article-title":"Pegylated liposomal doxorubicin in ovarian cancer","volume":"1","author":"Green","year":"2006","journal-title":"Int J Nanomedicine"},{"key":"key20180107211613_b16-or-35-06-3600","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ejps.2014.05.021","article-title":"Synthesis of Doxorubicin loaded magnetic chitosan nanoparticles for pH responsive targeted drug delivery","volume":"62","author":"Unsoy","year":"2014","journal-title":"Eur J Pharm Sci"},{"key":"key20180107211613_b17-or-35-06-3600","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1021\/bm3018577","article-title":"Encapsulation of antitumor drug Doxorubicin and its analogue by chitosan nanoparticles","volume":"14","author":"Sanyakamdhorn","year":"2013","journal-title":"Biomacromolecules"},{"key":"key20180107211613_b18-or-35-06-3600","doi-asserted-by":"crossref","first-page":"9065","DOI":"10.1016\/j.biomaterials.2010.08.039","article-title":"Multifunctional SPIO\/DOX-loaded wormlike polymer vesicles for cancer therapy and MR imaging","volume":"31","author":"Yang","year":"2010","journal-title":"Biomaterials"},{"key":"key20180107211613_b19-or-35-06-3600","doi-asserted-by":"crossref","first-page":"4539","DOI":"10.1021\/nn100690m","article-title":"Engineered design of mesoporous silica nanoparticles to deliver doxorubicin and P-glycoprotein siRNA to overcome drug resistance in a cancer cell line","volume":"4","author":"Meng","year":"2010","journal-title":"ACS Nano"},{"key":"key20180107211613_b20-or-35-06-3600","first-page":"1697","article-title":"Co-encapsulation of magnetic Fe3O4 nanoparticles and doxorubicin into biodegradable PLGA nanocarriers for intratumoral drug delivery","volume":"7","author":"Jia","year":"2012","journal-title":"Int J Nanomedicine"},{"key":"key20180107211613_b21-or-35-06-3600","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jconrel.2005.09.034","article-title":"Block copolymer micelles: Preparation, characterization and application in drug delivery","volume":"109","author":"Gaucher","year":"2005","journal-title":"J Control Release"},{"key":"key20180107211613_b22-or-35-06-3600","doi-asserted-by":"crossref","first-page":"7668","DOI":"10.1158\/0008-5472.CAN-04-2550","article-title":"Nanoparticle-aptamer bioconjugates: A new approach for targeting prostate cancer cells","volume":"64","author":"Farokhzad","year":"2004","journal-title":"Cancer Res"},{"key":"key20180107211613_b23-or-35-06-3600","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.1016\/j.biomaterials.2008.07.007","article-title":"The biocompatibility of mesoporous silicates","volume":"29","author":"Hudson","year":"2008","journal-title":"Biomaterials"},{"key":"key20180107211613_b24-or-35-06-3600","doi-asserted-by":"crossref","first-page":"73ra21","DOI":"10.1126\/scitranslmed.3001713","article-title":"Nanodiamond therapeutic delivery agents mediate enhanced chemoresistant tumor treatment","volume":"3","author":"Chow","year":"2011","journal-title":"Sci Transl Med"},{"key":"key20180107211613_b25-or-35-06-3600","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/wnan.40","article-title":"Top-down particle fabrication: Control of size and shape for diagnostic imaging and drug delivery","volume":"1","author":"Canelas","year":"2009","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"key20180107211613_b26-or-35-06-3600","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.1016\/j.biomaterials.2004.10.012","article-title":"Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications","volume":"26","author":"Gupta","year":"2005","journal-title":"Biomaterials"},{"key":"key20180107211613_b27-or-35-06-3600","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1109\/TNB.2003.820277","article-title":"Surface-modified superparamagnetic nanoparticles for drug delivery: Preparation, characterization, and cytotoxicity studies","volume":"3","author":"Gupta","year":"2004","journal-title":"IEEE Trans Nanobioscience"},{"key":"key20180107211613_b28-or-35-06-3600","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.1021\/nn201010q","article-title":"Remote triggered release of doxorubicin in tumors by synergistic application of thermosensitive liposomes and gold nanorods","volume":"5","author":"Agarwal","year":"2011","journal-title":"ACS Nano"},{"key":"key20180107211613_b29-or-35-06-3600","first-page":"6387","article-title":"A new concept for macromolecular therapeutics in cancer chemotherapy: Mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs","volume":"46","author":"Matsumura","year":"1986","journal-title":"Cancer Res"},{"key":"key20180107211613_b30-or-35-06-3600","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/jbm.a.31800","article-title":"Effect of polymer architecture on surface properties, plasma protein adsorption, and cellular interactions of pegylated nanoparticles","volume":"87","author":"Sant","year":"2008","journal-title":"J Biomed Mater Res A"},{"key":"key20180107211613_b31-or-35-06-3600","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.eurpolymj.2015.02.041","article-title":"Zwitterionic polymeric micelles that undergo a pH-triggered positive charge for enhanced cellular uptake","volume":"66","author":"Lu","year":"2015","journal-title":"Eur Polym J"},{"key":"key20180107211613_b32-or-35-06-3600","doi-asserted-by":"crossref","first-page":"12928","DOI":"10.1021\/jp905781g","article-title":"Poly(epsilon-caprolactone)\/poly(ethylene glycol)\/poly(epsilon-caprolactone) nanoparticles: Preparation, characterization, and application in doxorubicin delivery","volume":"113","author":"Gou","year":"2009","journal-title":"J Phys Chem B"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2016.4748\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T16:16:24Z","timestamp":1515341784000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2016.4748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,15]]},"references-count":32,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2016,4,15]]},"published-print":{"date-parts":[[2016,6]]}},"alternative-id":["10.3892\/or.2016.4748"],"URL":"https:\/\/doi.org\/10.3892\/or.2016.4748","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,15]]}}}